Living with Progressive Multiple Sclerosis? Take Part in Study to Develop Better Treatment Options

If you’re living with progressive MS, you may be able to join a clinical trial testing a potential new treatment that may slow decline, reduce relapses, and help people stay active for longer. These clinical trials are taking place in Christchurch and Auckland. Clinical trials are the backbone of medical progress, rigorously testing drugs and […]
‘Exhaustion and dread’ : Desperate carer calls for change

Speaking in support of the Carers Alliance petition, Maxine Hall, a carer for her husband with Multiple Sclerosis, speaks of her struggles and hopes that this campaign will at least raise awareness. View original article on Otago Daily Times: https://www.odt.co.nz/news/dunedin/exhaustion-and-dread-desperate-carer-calls-change A Mosgiel caregiver desperate for a break after averaging fewer than four days off […]
Fatigue in Progressive MS – Webcast

Fatigue is one of the most common, troubling symptoms experienced by people with progressive MS. For many people, it is the symptom that affects them most. Join MSIF to learn about the latest advances in treatment and research in fatigue during this 30-minute global webcast. An international panel of MS experts will answer questions submitted […]
Andrew – Passionate poet and crafter

Andrew Hodson was diagnosed with Secondary Progressive MS (SPMS) in 2008. “I probably had it for 20 years before that. A mixture of symptoms appeared then went away, including numb legs plus pins and needles. The initial diagnosis was very confronting, and I shed many tears.” Shocked by what he was hearing, Andrew can’t recall […]
Recording available – Progressive MS Treatment and Research

Learn about the latest advances in progressive MS research and treatment during this 30-minute International Progressive MS Alliance webcast. An international panel of MS experts will answer questions submitted by people affected by MS from throughout the world. From symptom management and well-being to the development of treatments that can slow progression and rebuild myelin, […]
